DK0060336014
© Globe Newswire
21.11.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
06.11.2025
NSIS B
LISTED
CPH
Novonesis delivered 8% organic sales growth in the first nine months of 2025
News Preview
Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. ...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
06.11.2025
NSIS B
LISTED
CPH
8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.
News Preview
Ester Baiget, President & CEO: ”I am pleased with our performance in the first nine months, where we delivered 8% organic sales growth with solid profitability and cash flow. Our performance was strong across all sales areas and in Emerging and Developed Markets. We delivered 37.3% adjusted EBITDA margin, despite significant currency headwinds,...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.11.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
NSIS B
LISTED
CPH
Noma and Novonesis partner to scale deliciousness
News Preview
Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the next level. Together, they’re fusing culinary craft with biology to create flavors and products that are healthier, tastier, and better for the planet...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
NSIS B
LISTED
CPH
Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters
News Preview
Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton, North Carolina, for the national flagship Manufacturing Da...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.09.2025
NSIS B
LISTED
CPH
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
News Preview
Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
NSIS B
LISTED
CPH
Amendment: Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
22.08.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.08.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
NSIS B
LISTED
CPH
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
News Preview
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
NSIS B
LISTED
CPH
Interim report H1 2025
News Preview
9% organic sales growth in H1 and FY outlook range narrowed to 6-8%...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
NSIS B
LISTED
CPH
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
News Preview
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
NSIS B
LISTED
CPH
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
News Preview
Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of ~39% and an adjusted ROIC excl. goodwil...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.07.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Please read the full announcement in PDF....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.07.2025
NSIS B
LISTED
CPH
Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe
News Preview
Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.06.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated 1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement N...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.06.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
19.06.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.06.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.06.2025
NSIS B
LISTED
CPH
Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance
News Preview
Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced on February 11, 2025 (announcement No 2)....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.05.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.05.2025
NSIS B
LISTED
CPH
Combining EVP roles of Human Health Biosolutions and Strategy & Integration
News Preview
As a next step on Novonesis’ integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
NSIS B
LISTED
CPH
Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook
News Preview
COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The company maintains the full-year outlook....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
NSIS B
LISTED
CPH
Interim report Q1 2025
News Preview
Strong start to the year and confirmed full-year outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.04.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.04.2025
NSIS B
LISTED
CPH
Andrew Taylor joins Novonesis’ Executive Leadership Team
News Preview
Andrew Taylor will assume the role as EVP of Food & Beverage Biosolutions at Novonesis....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.04.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.04.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.03.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.03.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.03.2025
NSIS B
LISTED
CPH
Initiation of share buyback program
News Preview
On March 5, 2025, Novonesis will initiate a share buyback program as announced in Company Announcement No. 3 of February 26, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million in total during the remainder of 2025, corresponding to around 1.7 million B shares at the current share price. The program is contingent u...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.03.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
The Executive Leadership Team members eligible for the Novozymes A/S 2022-2024 incentive program has on February 26, 2025, received the allocated shares. An overview of the number and value of shares allotted is provided on the attached file....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.02.2025
NSIS B
LISTED
CPH
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
News Preview
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of 37-38%. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.02.2025
NSIS B
LISTED
CPH
Change to the Executive Leadership Team
News Preview
Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
NSIS B
LISTED
CPH
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
News Preview
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm-firmenich allowed this opportunity to materialize. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.02.2025
NSIS B
LISTED
CPH
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
News Preview
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5 billion. After more than 25 years of successful collaboration, a strategic repositioning at dsm-firmenich allowed this opportunity to materialize. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.01.2025
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.11.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.11.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2024
NSIS B
LISTED
CPH
Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%
News Preview
Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong performance has led Novonesis to now expect full-year organic sales growth to be at the upper end of the 7-8% range, and the adjusted EBITDA margin is con...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2024
NSIS B
LISTED
CPH
Trading statement 9M 2024
News Preview
Organic pro forma sales growth of 9%, including 11% in the third quarter. Full-year organic sales growth outlook now expected at the upper end of the 7-8% range and the adjusted EBITDA margin confirmed between 35.5-36.5%....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.11.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Announcement released on November 4, 2024 at 10:07:51 CET did not include PDF file....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.11.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2024
NSIS B
LISTED
CPH
New employee-elected board member
News Preview
Company announcement No. 42...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please see the attached PDF for details....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
